Literature DB >> 16021589

Do different psychotic experiences differentially predict need for care in the general population?

Maarten Bak1, Inez Myin-Germeys, Philippe Delespaul, Wilma Vollebergh, Ron de Graaf, Jim van Os.   

Abstract

INTRODUCTION: The pathway from subclinical psychotic experiences to need for care may depend on type of psychotic experience, level of associated distress, and previous experience of psychosis.
METHOD: In a general population sample with no previous Diagnostic and Statistical Manual of Mental Disorders , Revised Third Edition , psychotic disorder (n = 4722), 83 subjects displayed at least one psychotic experience. Within the group of 83, subjects with (n = 24) and without need for care (n = 59) were compared. Presence of psychotic experiences at younger ages had been assessed at earlier interviews.
RESULTS: Of 7 different psychotic experiences, only hearing voices, nonverbal hallucinations, and passivity phenomena were significantly associated with need for care. These associations were largely explained by the distress associated with the psychotic experience, but whether individuals had had psychotic experiences at earlier ages did not matter.
CONCLUSIONS: Different psychotic experiences differ in the associated level of need for care and the mediating role of distress. Longer prior exposure to psychosis may not influence the pathway from subclinical to clinical.

Entities:  

Mesh:

Year:  2005        PMID: 16021589     DOI: 10.1016/j.comppsych.2004.08.003

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  The psychometric properties of the Peters et al. delusions inventory (PDI) in Taiwan: reliability, validity, and utility.

Authors:  Yu-Chen Kao; Tzong-Shi Wang; Chien-Wen Lu; Tsung-Hsing Cheng; Yia-Ping Liu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-08-23       Impact factor: 4.328

2.  Distress, Impairment and the Extended Psychosis Phenotype: A Network Analysis of Psychotic Experiences in an US General Population Sample.

Authors:  Jamie Murphy; Orla McBride; Eiko Fried; Mark Shevlin
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

3.  Assessing anomalous perceptual experiences in nonpsychiatric individuals and outpatients with psychosis in Taiwan: an investigation using the cardiff anomalous perceptions scale (CAPS).

Authors:  Yu-Chen Kao; Tzong-Shi Wang; Chien-Wen Lu; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2013-06

4.  Lifetime and Momentary Psychotic Experiences in Adult Males and Females With an Autism Spectrum Disorder.

Authors:  Kim van der Linden; Claudia Simons; Thérèse van Amelsvoort; Machteld Marcelis
Journal:  Front Psychiatry       Date:  2020-08-03       Impact factor: 4.157

5.  Relationships of perceived public stigma of mental illness and psychosis-like experiences in a non-clinical population sample.

Authors:  Yin-Ju Lien; Yu-Chen Kao; Yia-Ping Liu; Hsin-An Chang; Nian-Sheng Tzeng; Chien-Wen Lu; Shwu-Jon Lin; Ching-Hui Loh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-23       Impact factor: 4.328

6.  The structure of the extended psychosis phenotype in early adolescence--a cross-sample replication.

Authors:  Johanna T W Wigman; Wilma A M Vollebergh; Quinten A W Raaijmakers; Jurjen Iedema; Saskia van Dorsselaer; Johan Ormel; Frank C Verhulst; Jim van Os
Journal:  Schizophr Bull       Date:  2009-12-31       Impact factor: 9.306

7.  An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis.

Authors:  Maarten Bak; Marjan Drukker; Laila Hasmi; Jim van Os
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

8.  Psychotic Experiences, Working Memory, and the Developing Brain: A Multimodal Neuroimaging Study.

Authors:  Leon Fonville; Kathrin Cohen Kadosh; Mark Drakesmith; Anirban Dutt; Stanley Zammit; Josephine Mollon; Abraham Reichenberg; Glyn Lewis; Derek K Jones; Anthony S David
Journal:  Cereb Cortex       Date:  2015-08-18       Impact factor: 5.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.